References
- Anderson F H. Osteoporosis in men. Int J Clin Pract 1998; 53: 176–80
- Huuskonen J, Kroger H, Alhava E. Characteristics of male hip fracture patients. Ann Chir Gynaecol 1999; 88: 48–53
- Myers A H, Robinson E G, Van Natta M L. Hip fractures among the elderly: factors associated with in-hospital mortality. Am J Epidemiol 1991; 134: 1128–37
- Schurch M A, Rizzoli R, Mermillod B. A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Mineral Res 1996; 11: 1935–42
- US Bureau of the Census. International Population Reports, P95/92–3. An Aging World II. US Government Printing Office, Washington, DC 1999
- European Commission. Report on Osteoporosis in the European Community. Action for Prevention. Office for Official Publications of the European Communities, Luxembourg 1998
- O'Neil T W, Felsenberg D, Varlow J. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Mineral Res 1996; 11: 1010–18
- Burger H, vanDaele P LA, Grashuis K. Vertebral deformities and functional impairment in men and women. J Bone Mineral Res 1997; 12: 152–7
- Melton LJ I II, Chrischilles E A. Perspective: how many women have osteoporosis?. J Bone Mineral Res 1992; 7: 1005–10
- Riggs B L, Khosla S, Melton LJ I II. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Mineral Res 1998; 13: 763–73
- Seeman E. The structural basis of bone fragility in men. Bone 1999; 25: 143–7
- Diaz M N, O'Neill T W, Silman A J. The influence of family history of hip fracture on the risk of vertebral deformity in men and women: the European Vertebral Osteoporosis Study. Bone 1997; 20: 145–9
- Zmuda J M, Cauley J A, Ferrell R E. Recent progress in understanding the genetic susceptibility to osteoporosis. Genet Epidemiol 1999; 16: 356–67
- Orwoll E S, Oviatt S K, McClung M R, Deftos L J, Sexton G. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med 1990; 112: 29–34
- Orwoll E S, Meier D E. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia. Clin Endocrinol Metab 1986; 63: 1262–9
- Khosla S, Melton LJ I II, Riggs B L. Osteoporosis: gender differences and similarities. Lupus 1999; 8: 393–6
- Peris P, Guanabens N, Monegral A, Suris X, Alvarez L, Martinez de Osaba M J, et al. Aetiology and presenting symptoms in male osteoporosis. Br J Rheumatol 1995; 34: 936–41
- Kanis J, Johnell O, Gulberg B, Allander E, Elffors L, Ranstam J, et al. Risk factors for hip fracture in men from Southern Europe: the MEDOS Study. Osteoporos Int 1999; 9: 45–54
- Eastell R, Boyle I T, Compston J, Cooper C, Fogelman I, Francis R M, et al. Management of male osteoporosis: report of the UK Consensus group. Q J Med 1998; 91: 71–92
- Walsh L J, Wong C A, Pringle M, Tattersfield A E. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. Br Med J 1996; 313: 344–6
- Behere H M, Kliesch S, Leifke E. Long term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 2386–90
- Rodino M A, Shane E. Osteoporosis after organ transplantation. Am J Med 1998; 104: 459–69
- Orwoll E S. Osteoporosis in men. Endocr Metab Clin North Am 1998; 27: 349–67